Home
>
National Drug Code (NDC)
>
JANUMET
JANUMET - 0006-0575-52 - (SITAGLIPTIN and METFORMIN HYDROCHLORIDE)
Drug Information of JANUMET
| Product NDC: | 0006-0575 |
| Proprietary Name: | JANUMET |
| Non Proprietary Name: | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
| Active Ingredient(s): | 500; 50 mg/1; mg/1 & nbsp; SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of JANUMET
| Product NDC: | 0006-0575 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022044 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070330 |
Package Information of JANUMET
| Package NDC: | 0006-0575-52 |
| Package Description: | 5 BLISTER PACK in 1 CARTON (0006-0575-52) > 10 TABLET, FILM COATED in 1 BLISTER PACK (0006-0575-01) |
NDC Information of JANUMET
| NDC Code | 0006-0575-52 |
| Proprietary Name | JANUMET |
| Package Description | 5 BLISTER PACK in 1 CARTON (0006-0575-52) > 10 TABLET, FILM COATED in 1 BLISTER PACK (0006-0575-01) |
| Product NDC | 0006-0575 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20070330 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE |
| Strength Number | 500; 50 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
